Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. He (Nan Ning, China), Y. Qi (Nan Ning, China). Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease. 2988

Member's Comments

No comment yet.

Related content which might interest you: Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis Source: Eur Respir J 2012; 39: 1354-1360 Year: 2012 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Blood eosinophilia in chronic obstructive pulmonary disease: impact on exacerbations risk and severity Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 Bronchial colonization and inflammatory response in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation Source: Eur Respir J 2001; 18: Suppl. 33, 540s Year: 2001 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Micro-RNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Calorie-intake in patients hospitalized for an acute COPD exacerbation Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 Antibiotics in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China Source: International Congress 2017 – COPD biomarkers Year: 2017